BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2022 9:40:09 AM | Browse: 245 | Download: 314
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 65270
Country/Territory United Kingdom
Received
2021-03-17 23:14
Peer-Review Started
2021-03-17 23:19
To Make the First Decision
Return for Revision
2021-05-03 04:57
Revised
2021-05-15 21:57
Second Decision
2022-03-23 06:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-03-27 07:01
Articles in Press
2022-03-27 07:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-04-01 11:17
Publish the Manuscript Online
2022-04-15 09:40
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Vasoactive intestinal peptide secreting tumour: An overview
Manuscript Source Invited Manuscript
All Author List Esther Una Cidon
ORCID
Author(s) ORCID Number
Esther Una Cidon http://orcid.org/0000-0002-8650-5821
Funding Agency and Grant Number
Corresponding Author Esther Una Cidon, MD, MSc, PhD, Doctor, Department of Medical Oncology, University Hospitals Dorset, Medical Oncology Service, Royal Bournemouth Hospital, Castle Lane East, Bournemouth BH7 7DW, Dorset, United Kingdom. aunacid@hotmail.com
Key Words VIPoma; Octreotide; Secretory diarrhoea; Multiple endocrine neoplasia; Vasoactive intestinal peptide; Vermer-Morrison syndrome
Core Tip Vasoactive intestinal peptide (VIP) secreting tumour (VIPoma) is a rare functional neuroendocrine tumour that typically arises from pancreatic islet cells. It is usually sporadic but may present as part of the endocrine neoplasia type I syndrome in 5% of cases. Excessive VIP secretion produces a refractory secretory diarrhoea which left untreated will cause patient's death. The majority of VIPomas are malignant and have already metastasized at the time of diagnosis (60%), being the liver, or regional lymph nodes the most frequent site for metastases. Complete surgical resection is the only potentially curative treatment, however, surgical debulking may provide palliative benefit. Other palliative options include somatostatin analogues and recently the peptide receptor radionuclide therapy which has shown to be effective and well-tolerated.
Publish Date 2022-04-15 09:40
Citation Una Cidon E. Vasoactive intestinal peptide secreting tumour: An overview. World J Gastrointest Oncol 2022; 14(4): 808-819
URL https://www.wjgnet.com/1948-5204/full/v14/i4/808.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i4.808
Full Article (PDF) WJGO-14-808.pdf
Full Article (Word) WJGO-14-808.docx
Manuscript File 65270_Auto_Edited.docx
Answering Reviewers 65270-Answering reviewers.pdf
Audio Core Tip 65270-Audio core tip.aac
Conflict-of-Interest Disclosure Form 65270-Conflict-of-interest statement.pdf
Copyright License Agreement 65270-Copyright license agreement.pdf
Peer-review Report 65270-Peer-review(s).pdf
Scientific Misconduct Check 65270-Bing Liu M-1.png
Scientific Misconduct Check 65270-Bing-Chang KL-2.png
Scientific Editor Work List 65270-Scientific editor work list.pdf